Berlin, Germany

Carlos Castellon

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Castellon. Retrieved from https://idiyas.com/inventor/carlos-castellon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Carlos Castellon in Patient Drug Management

Introduction

Carlos Castellon is an innovative inventor based in Berlin, Germany. He has made significant contributions to the field of healthcare technology, particularly in the area of patient medication management. His work focuses on enhancing the effectiveness of therapeutic treatments through improved drug adherence.

Latest Patents

Carlos Castellon holds a patent for a method and system designed to support patients in the repeated taking of drugs. This invention relates to monitoring the administration of medication by patients and providing timely notifications to patients, doctors, or caregivers when a drug portion should not be taken. This innovative approach aims to optimize treatment effectiveness and reduce potential risks associated with medication errors. He has 1 patent to his name.

Career Highlights

Carlos Castellon is currently employed at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer allows him to work on cutting-edge projects that aim to improve patient outcomes through technology. His expertise in drug management systems has positioned him as a valuable asset in the healthcare innovation landscape.

Collaborations

Throughout his career, Carlos has collaborated with notable colleagues, including Hubert Trübel and Philip Patrick Böhme. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in the healthcare sector.

Conclusion

Carlos Castellon's contributions to patient drug management exemplify the importance of innovation in healthcare. His patent and work at Bayer reflect a commitment to improving patient safety and treatment efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…